StockStory.org on MSN
DexCom (NASDAQ:DXCM) exceeds Q1 CY2026 expectations but stock drops
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results , with sales up 15% year on year to $1.19 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results